Evidence map›Paper›PMID 31762875›Full record

ArticleThe Pan African medical journal2019

Modifiable predictors of severe heart failure in Morocco: a descriptive study using routinely collected health data.

Alpha Kone, Mahamoud Sama Cherif, Dahal Prabin, Shyam Prakash Dumre, Almamy Ibrahim Doumbouya, Diane Fotso Kapche, Facely Camara, Serbout Saousan, Khaddi Sara, Mandiou Diakite and 3 more

Abstract read
In one paragraph

Article in The Pan African medical journal, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Alpha KoneDepartment of Cardiology, Ibn Rochd Hospital, Faculty of Medicine and Pharmacy, Hassan II University of Casablanca, Morocco.
Mahamoud Sama CherifFaculty of Medicine Pharmacy and Odontostomatology, Gamal Abdel Nasser University of Conakry, Conakry, Guinea.
Dahal PrabinInfectious Diseases Data Observatory, Centre for Tropical Medicine & Global Health, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, UK.
Shyam Prakash DumreInstitute of Tropical Medicine (NEKKEN), Nagasaki University, Nagasaki, Japan.
Almamy Ibrahim DoumbouyaDepartment of Cardiology, Ibn Rochd Hospital, Faculty of Medicine and Pharmacy, Hassan II University of Casablanca, Morocco.
Diane Fotso KapcheDepartment of Cardiology, Ibn Rochd Hospital, Faculty of Medicine and Pharmacy, Hassan II University of Casablanca, Morocco.
Facely CamaraFaculty of Medicine Pharmacy and Odontostomatology, Gamal Abdel Nasser University of Conakry, Conakry, Guinea.
Serbout SaousanDepartment of Cardiology, Ibn Rochd Hospital, Faculty of Medicine and Pharmacy, Hassan II University of Casablanca, Morocco.
Khaddi SaraDepartment of Cardiology, Ibn Rochd Hospital, Faculty of Medicine and Pharmacy, Hassan II University of Casablanca, Morocco.
Mandiou DiakiteFaculty of Medicine Pharmacy and Odontostomatology, Gamal Abdel Nasser University of Conakry, Conakry, Guinea.
Mohamed CisseFaculty of Medicine Pharmacy and Odontostomatology, Gamal Abdel Nasser University of Conakry, Conakry, Guinea.
Leila AzzouziDepartment of Cardiology, Ibn Rochd Hospital, Faculty of Medicine and Pharmacy, Hassan II University of Casablanca, Morocco.
Rachida HabbalDepartment of Cardiology, Ibn Rochd Hospital, Faculty of Medicine and Pharmacy, Hassan II University of Casablanca, Morocco.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionHeart Failure (HF) is a growing public health concern in Morocco and there is a striking paucity on determinants of severe HF (SHF) in this population. The aim of this study was to identify patients admitted with HF at Ibn Rochd Hospital, Casablanca from 2011 onwards, when electronic record keeping began.

methodsA total of 105 patients underwent a series of cardiological examinations between July 2011 and January 2014. The New York Heart Association (NYHA) criteria was used to evaluate the severity of HF. Patients with NYHA classification gradings of I and II were defined as having moderate HF (MHF) and those graded as III and IV were defined as having a SHF. Univariable and multivariable risk factors associated with SHF were explored using logistic regression. The results were reported following the RECORD (Reporting of studies Conducted using Observational Routinely-collected Data) statement.

resultsA total of 24 (33%) patients were identified as having a SHF. Four predictors of SHF were identified in univariate analysis: haemoglobin <12g/dL, neutrophil-to-lymphocyte ratio (NLR) >3, mean corpuscular haemoglobin concentration (MCHC) <32 picolitre, and high density lipoprotein (HDL) <0.35 (mmol/L). Only NLR>3 and HDL <0.35 mmol/L remained independent predictors in multivariable analysis. Patients with NLR >3 were at 6-fold increased odds of SHF [adjusted odds ratio (AOR): 6.78, 95% confidence interval (CI): 1.40-32.80, p=0.017], and those with HDL<0.35 (mmol/L) were at 10-fold increased odds of SHF [AOR: 10.11, 95% CI: 2.26-45.27, p=0.002].

conclusionThe independent biomarkers of SHF identified in this study provide valuable information to ward clinicians in resource-constrained facilities to identify patients vulnerable to developing severe heart complications.

Indexed as

AgedBiomarkersElectronic Health RecordsFemaleHeart FailureHemoglobinsHospitalizationHumansLymphocytesMaleMiddle AgedMoroccoNeutrophilsRisk FactorsSeverity of Illness IndexBiomarkersHemoglobinshdlHeart failureMorocconeutrophils-lymphocytes-ratio

Identifiers

PMID31762875
PMCPMC6850741

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.